(Q30768542)

26 June 2017

1 reference

title

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease (English)

1 reference

26 June 2017

1 reference

0 references

Tsuboi Y

1

1 reference

26 June 2017

Kakimoto K

2

1 reference

26 June 2017

Nakajima M

3

1 reference

26 June 2017

Akatsu H

4

1 reference

26 June 2017

Yamamoto T

5

1 reference

26 June 2017

Ogawa K

6

1 reference

26 June 2017

Ohnishi T

7

1 reference

26 June 2017

Daikuhara Y

8

1 reference

26 June 2017

Yamada T

9

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Acta Neurologica Scandinavica

26 June 2017

published in

1 reference

26 June 2017

volume

107

1 reference

26 June 2017

issue

2

1 reference

26 June 2017

page(s)

81-86

1 reference

Emerging multipotent aspects of hepatocyte growth factor

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Hepatocyte growth factor (HGF/SF) in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Astroglial expression of hepatocyte growth factor and hepatocyte growth factor activator in human brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

White matter astrocytes produce hepatocyte growth factor activator inhibitor in human brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Somatostatin and octreotide for variceal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Vascular changes in white matter lesions of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

The overlap between Alzheimer's disease and vascular dementia: the role of white matter changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Pathophysiologic mechanisms in the development of age-related white matter changes of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Hepatocyte growth factor specifically expressed in microglia activated Ras in the neurons, similar to the action of neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Development of highly sensitive enzyme-linked immunosorbent assays for hepatocyte growth factor/scatter factor (HGF/SF): determination of HGF/SF in serum and urine from normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

7 January 2021

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

7 January 2021

Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

7 January 2021

Hepatocyte growth factor in cerebrospinal fluid in neurologic disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

7 January 2021

Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

7 January 2021

Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

7 January 2021

Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

7 January 2021

A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.02089.X

7 January 2021

10.1034/J.1600-0404.2003.02089.X

Identifiers

DOI

1 reference

26 June 2017

1 reference